Addex Therapeutics Quick Ratio 2021-2025 | ADXN

Historical quick ratio values for Addex Therapeutics (ADXN) over the last 10 years.

Addex Therapeutics Quick Ratio Historical Data
Date	Current Assets - Inventory	Current Liabilities	Quick Ratio
2025-06-30	$0.00B	$0.00B	0.00
2025-03-31	$0.00B	$0.00B	0.00
2024-12-31	$0.00B	$0.00B	0.00
2024-09-30	$0.00B	$0.00B	0.00
2024-06-30	$0.00B	$0.00B	0.00
2024-03-31	$0.00B	$0.01B	0.00
2023-12-31	$0.00B	$0.00B	0.00
2023-09-30	$0.00B	$0.00B	0.00
2023-06-30	$0.00B	$0.00B	0.00
2023-03-31	$0.00B	$0.00B	0.00
2022-12-31	$0.00B	$0.00B	0.00
2022-09-30	$0.00B	$0.00B	0.00
2022-06-30	$0.00B	$0.00B	0.00
2022-03-31	$0.00B	$0.00B	0.00
2021-12-31	$0.00B	$0.01B	0.00
2021-09-30	$0.00B	$0.00B	0.00
2021-06-30	$0.00B	$0.00B	0.00
2021-03-31	$0.00B	$0.01B	0.00
2020-12-31	$0.00B	$0.00B	0.00
2020-09-30	$0.00B	$0.00B	0.00
2020-06-30	$0.00B	$0.00B	0.00
2020-03-31	$0.00B	$0.01B	0.00

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.010B	$0.000B
Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include GABAB PAM for CMT1A, mGlu7 NAM for PTSD, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson's disease and mGlu3 PAM for neurodegenerative disorders. GABAB PAM program has been licensed to Indivior PLC for the treatment of addiction. Addex Therapeutics Ltd is based in Geneva, Switzerland.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$86.554B	32.88
Zoetis (ZTS)	United States	$52.072B	18.64
Takeda Pharmaceutical (TAK)	Japan	$45.248B	9.23
Daiichi Sankyo, - (DSNKY)	Japan	$41.676B	20.75
BeOne Medicines - (ONC)	Switzerland	$38.701B	189.82
Sandoz Group AG (SDZNY)	Switzerland	$32.089B	0.00
United Therapeutics (UTHR)	United States	$20.646B	18.17
Merck (MKKGY)	Germany	$17.926B	11.05
Neurocrine Biosciences (NBIX)	United States	$15.453B	37.08
Shionogi (SGIOY)	Japan	$14.530B	13.34
Summit Therapeutics (SMMT)	United States	$14.363B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.203B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$12.913B	0.00
IPSEN (IPSEY)	France	$11.771B	0.00
Orion OYJ (ORINY)	Finland	$9.922B	28.35
Corcept Therapeutics (CORT)	United States	$8.729B	94.29
Eisai (ESAIY)		$8.679B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.505B	36.41
Ono Pharmaceutical (OPHLF)	Japan	$6.238B	18.97
Grifols, S.A (GRFS)	Spain	$6.174B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.620B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$4.498B	0.00
NewAmsterdam Pharma (NAMS)	Netherlands	$4.054B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.965B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.731B	17.72
Ocular Therapeutix (OCUL)	United States	$3.432B	0.00
Dyne Therapeutics (DYN)	United States	$3.171B	0.00
Hypermarcas (HYPMY)	Brazil	$2.850B	19.57
Catalyst Pharmaceuticals (CPRX)	United States	$2.847B	9.08
Soleno Therapeutics (SLNO)	United States	$2.749B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.082B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.067B	24.50
Guardian Pharmacy Services (GRDN)	United States	$1.812B	34.90
Harrow (HROW)	United States	$1.758B	107.89
BioCryst Pharmaceuticals (BCRX)	United States	$1.621B	96.25
Oruka Therapeutics (ORKA)	United States	$1.522B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.514B	7.50
Amylyx Pharmaceuticals (AMLX)	United States	$1.501B	0.00
Ardelyx (ARDX)	United States	$1.429B	0.00
Relay Therapeutics (RLAY)	United States	$1.322B	0.00
Savara (SVRA)	United States	$1.316B	0.00
Xencor (XNCR)	United States	$1.263B	0.00
Enliven Therapeutics (ELVN)	United States	$1.218B	0.00
Nektar Therapeutics (NKTR)	United States	$1.165B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.160B	0.00
Evotec AG (EVO)	Germany	$1.069B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.988B	0.00
Cronos Group (CRON)	Canada	$0.946B	0.00
Esperion Therapeutics (ESPR)	United States	$0.935B	0.00
Theravance Biopharma (TBPH)	United States	$0.918B	38.55
KalVista Pharmaceuticals (KALV)	United States	$0.852B	0.00
Aquestive Therapeutics (AQST)	United States	$0.808B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.788B	7.03
ProKidney (PROK)	United States	$0.707B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.690B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.633B	0.00
Lyell Immunopharma (LYEL)	United States	$0.602B	0.00
Bioventus (BVS)	United States	$0.595B	12.19
Organogenesis (ORGO)	United States	$0.591B	0.00
Altimmune (ALT)	United States	$0.585B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.564B	13.35
Elite Pharmaceuticals (ELTP)	United States	$0.555B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.494B	0.00
Siga Technologies (SIGA)	United States	$0.440B	6.03
Akebia Therapeutics (AKBA)	United States	$0.430B	0.00
Galectin Therapeutics (GALT)	United States	$0.388B	0.00
Nature's Sunshine Products (NATR)	United States	$0.366B	21.78
Aclaris Therapeutics (ACRS)	United States	$0.355B	0.00
USANA Health Sciences (USNA)	United States	$0.355B	9.90
Avalo Therapeutics (AVTX)	United States	$0.353B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.326B	0.00
Larimar Therapeutics (LRMR)	United States	$0.316B	0.00
Relmada Therapeutics (RLMD)	United States	$0.306B	0.00
Fractyl Health (GUTS)	United States	$0.306B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.298B	0.00
OmniAb (OABI)	United States	$0.286B	0.00
Pyxis Oncology (PYXS)	United States	$0.260B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.250B	0.00
Heron Therapeutics (HRTX)	United States	$0.248B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.234B	0.00
Journey Medical (DERM)	United States	$0.223B	0.00
Protara Therapeutics (TARA)	United States	$0.221B	0.00
AleAnna (ANNA)	United States	$0.218B	0.00
MediWound (MDWD)	Israel	$0.205B	0.00
Profound Medical (PROF)	Canada	$0.205B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.182B	0.00
Surrozen (SRZN)	United States	$0.175B	0.00
Innate Pharma SA (IPHYF)	France	$0.167B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.160B	0.00
Cassava Sciences (SAVA)	United States	$0.155B	0.00
Gain Therapeutics (GANX)	United States	$0.153B	0.00
Incannex Healthcare (IXHL)	Australia	$0.150B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.141B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.108B	0.00
Vivani Medical (VANI)	United States	$0.106B	0.00
Avita Medical (RCEL)	United States	$0.105B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.100B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.099B	0.00
Context Therapeutics (CNTX)	United States	$0.097B	0.00
Prelude Therapeutics (PRLD)	United States	$0.092B	0.00
VAXART, INC (VXRT)	United States	$0.088B	0.00
Plus Therapeutics (PSTV)	United States	$0.087B	0.00
Champions Oncology (CSBR)	United States	$0.086B	31.30
Acrivon Therapeutics (ACRV)	United States	$0.080B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.077B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.072B	0.00
Korro Bio (KRRO)	United States	$0.071B	0.00
Rafael Holdings (RFL)	United States	$0.069B	0.00
Metagenomi (MGX)	United States	$0.068B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Lite Strategy (LITS)	United States	$0.063B	0.00
PolyPid (PYPD)	Israel	$0.063B	0.00
Arch Biopartners (ACHFF)	Canada	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Dominari Holdings (DOMH)	United States	$0.061B	0.00
Talphera (TLPH)	United States	$0.060B	0.00
Nutriband (NTRB)	United States	$0.059B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.055B	0.00
Wellgistics Health (WGRX)	United States	$0.055B	0.00
Century Therapeutics (IPSC)	United States	$0.050B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.048B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.039B	0.00
ElectroCore (ECOR)	United States	$0.039B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
FibroGen (FGEN)	United States	$0.034B	0.00
Klotho Neurosciences (KLTO)	United States	$0.033B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.032B	27.12
Vyome Holdings (HIND)	United States	$0.032B	0.00
Inotiv (NOTV)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.027B	0.00
Scienture Holdings (SCNX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.023B	0.00
Natural Alternatives (NAII)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
TherapeuticsMD (TXMD)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.019B	0.00
Lipocine (LPCN)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.018B	0.00
Traws Pharma (TRAW)	United States	$0.017B	0.02
Heatwurx (PCSA)	United States	$0.016B	0.00
Cosmos Health (COSM)	United States	$0.016B	0.00
Mangoceuticals (MGRX)	United States	$0.016B	0.00
BioLineRx (BLRX)	Israel	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.013B	0.00
VYNE Therapeutics (VYNE)	United States	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
BioVie (BIVI)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.011B	0.00
Ainos (AIMD)	United States	$0.011B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.010B	0.00
Aptorum Group (APM)	United Kingdom	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.007B	0.00
ProPhase Labs (PRPH)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.005B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Jaguar Animal Health (JAGX)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
CDT Equity (CDT)	United States	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.003B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Aditxt (ADTX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Indivior (INDV)	United States	$0.000B	18.67
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Minerva Neurosciences (NERV)	United States	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00